Literature DB >> 9066100

Helicobacter pylori and congestive gastropathy.

A Bahnacy1, P Kupcsulik, Z S Elés, B Jàray, L Flautner.   

Abstract

This study evaluates the prevalence and significance of Helicobacter pylori (H. Pylori) infection in patients with portal hypertension. 118 patients were selected, i. e. 90 patients with portal hypertension (66 males, 24 females, mean age 49.1 +/- 2.1 years) and 28 noncirrhotic patients with nonulcerative dyspepsia as a control group (twelve males, 16 females, mean age 47.6 +/- 2.8 years). In all patients diagnostic upper endoscopy was performed and gastric biopsies were taken for histological examination and diagnosis of H. pylori infection. Of the portal hypertensive patients, 42 patients (47%) had congestive gastropathy, eleven (26%) of whom were positive for H. pylori infection and 48 (53%) did not have gastropathy, twelve (25%) of whom were positive for H. pylori infection. In the control group, 15 of 28 (54%) were positive for H. pylori infection. H. pylori was found less frequently in congestive gastropathy patients than in the control group. We found also that the presence and severity of congestive gastropathy is independent of the H. pylori status. We conclude that the role of H. pylori infection in the pathogenesis of congestive gastropathy seems to be unlikely and we suggest that there is no need for its routine eradication in cirrhotic patients.

Entities:  

Mesh:

Year:  1997        PMID: 9066100

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  7 in total

Review 1.  Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome.

Authors:  K W Burak; S S Lee; P L Beck
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

2.  Liver disease and Helicobacter.

Authors:  Yu-Qin Luo; Jin-Bo Teng; Bo-Rong Pan; Xue-Yong Zhang
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

3.  Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.

Authors:  Mihajlo Gjeorgjievski; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2016-02-08

4.  Prevalence of Helicobacter pylori and occurrence of gastroduodenal lesions in patients with liver cirrhosis.

Authors:  Gabriele I Kirchner; Winfried Beil; Joerg S Bleck; Micheal P Manns; Siegfried Wagner
Journal:  Int J Clin Exp Med       Date:  2010-12-25

5.  Effect of endoscopic variceal obliteration by band ligation on portal hypertensive gastro-duodenopathy: endoscopic and pathological study.

Authors:  Reda Elwakil; Ashraf Mohammad Al Breedy; Hoda Hassan Abou Gabal
Journal:  Hepatol Int       Date:  2016-03-01       Impact factor: 6.047

6.  Effect of Helicobacter pylori and its virulence factors on portal hypertensive gastropathy and interleukin (IL)-8, IL-10, and tumor necrosis factor-alpha levels.

Authors:  Zaigham Abbas; Javed Yakoob; Muhammad W Usman; Tanzila Shakir; Saeed Hamid; Wasim Jafri
Journal:  Saudi J Gastroenterol       Date:  2014 Mar-Apr       Impact factor: 2.485

7.  Helicobacter pylori infection is not associated with portal hypertension-related gastrointestinal complications: A meta-analysis.

Authors:  Yu Kyung Jun; Ji Won Kim; Byeong Gwan Kim; Kook Lae Lee; Yong Jin Jung; Won Kim; Hyun Sun Park; Dong Hyeon Lee; Seong-Joon Koh
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.